In development: Guidance, quality standards and advice
Showing 1 to 1 of 1
| Title | Type | Expected publication date |
|---|---|---|
| Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227] | Technology appraisal guidance | TBC |
| Title | Type | Expected publication date |
|---|---|---|
| Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227] | Technology appraisal guidance | TBC |